Characterization and expression of the gyrA gene from quinolone resistant Yersinia ruckeri strains isolated from Atlantic salmon (Salmo salar L.) in Norway

Aquaculture

Volumn 350-353, Issue , 2012, Pages 37-41

  Shah, Syed Q A ^a   Karatas, Süheyla ^b   Nilsen, Hanne ^c   Steinum, Terje M ^c   Colquhoun, Duncan J ^c   Sørum, Henning ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NORWEGIAN VETERINARY INSTITUTE   (Norway)

Author keywords

Cloning; GyrA gene; Quinolone resistance; Yersinia ruckeri; Yersiniosis

Indexed keywords

ALLELE; ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; BACTERIUM; GENE EXPRESSION; JUVENILE; MUTATION; PATHOGEN; PLASMID; PROTEIN; SALMONID;

NORWAY;

ESCHERICHIA COLI; SALMO SALAR; SALMONIDAE; YERSINIA RUCKERI;

EID: 84862013349     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2012.04.022     Document Type: Article

References (34)

1. Alderman D.J., Smith P. Development of draft protocols of standard reference methods for antimicrobial agent susceptibility testing of bacteria associated with fish diseases. Aquaculture 2001, 196:211-243.
2. Barnes A.C., Lewin C.S., Hastings T.S., Amyes S.G.B. In vitro susceptibility of fish pathogen Aeromonas salmonicida to flumequine. Antimicrobial Agents and Chemotherapy 1991, 35:2634-2635.
3. Bastardo A., Sierralta V., Leon J., Ravelo C., Romalde J.s.L. Phenotypical and genetic characterization of Yersinia ruckeri strains isolated from recent outbreaks in farmed rainbow trout Oncorhynchus mykiss (Walbaum) in Peru. Aquaculture 2011, 317:229-232.
4. Berger S.A. Infectious Diseases of Norway 2011, Gideon Ebooks, 411pp.http://www.gideononline.com/ebooks/country/infectious-diseases-of-norway/.
5. Bridle A., Nosworthy E., Polinski M., Nowak B. Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri. PloS One 2011, 6.
6. CLSI Methods for Antimicrobial Disk Susceptibility Testing of Bacteria Isolated from Aquatic Animals, Approved Guidelines M42-A 2006, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
7. Colquhoun D.J., Aarflot L., Melvold C.F. gyrA and parC mutations and associated quinolone resistance in Vibrio anguillarum Serotype O2b strains isolated from farmed Atlantic cod (Gadus morhua) in Norway. Antimicrobial Agents and Chemotherapy 2007, 51:2597-2599.
8. Conchas R.F., Carniel E. A highly efficient electroporation system for transformation of Yersinia. Gene 1990, 87:133-137.
9. Furones M.D., Rodgers C.J., Munn C.B. Yersinia ruckeri, the causal agent of enteric redmouth disease (ERM) in fish. Annual Review of Fish Diseases 1993, 3:105-125.
10. Gibello A., Porrero M.C., Blanco M.M., Vela A.I., Liebana P., Moreno M.A., Fernandez-Garayzabal J.F., Dominguez L. Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones. Applied and Environmental Microbiology 2004, 70:599-602.
11. Hanahan D. Studies on transformation of Escherichia coli with plasmids. Journal of Molecular Biology 1983, 166:557-580.
12. Hane M.W., Wood T.H. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. Journal of Bacteriology 1969, 99:238-241.
13. Hawkey P.M. Mechanism of quinolone action and microbial response. Journal of Antimicrobial Chemotherapy 2003, 51:29-35.
14. Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy 1996, 40:879-885.
15. Higgins N.P., Cozzarelli N.R. The binding of gyrase to DNA: analysis by retention by nitrocellulose filters. Nucleic Acids Research 1982, 10:6833-6847.
16. Izumi S., Ouchi S., Kuge T., Arai H., Mito T., Fujii H., Aranishi F., Shimizu A. PCR-RFLP genotypes associated with quinolone resistance in isolates of Flavobacterium psychrophilum. Journal of Fish Diseases 2007, 30:141-147.
17. Karah N., Poirel L., Bengtsson S., Sundqvist M., Kahlmeter G., Nordmann P., Sundsfjord A., Samuelsen Ø., Norwagien The Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. Diagnostic Microbiology and Infectious Disease 2010, 66:425-431. The Norwagien study group on PMQR.
18. Khodursky A.B., Zechiedrich E.L., Cozzarelli N.R. Topoisomerase is a target of quinolones in Escherichia coli. Proceedings of the National Academy of Sciences 1995, 92:11801-11805.
19. Kronvall G. Determination of the real standard distribution of susceptible strains in zone histograms. International Journal of Antimicrobial Agents 2003, 22:7-13.
20. Levine C., Hiasa H., Marians K.J. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochimica et Biophysica Acta 1998, 1400:29-43.
21. Maxwell A. The molecular basis of quinolone resistance. Journal of Antimicrobial Chemotherapy 1992, 30:409-416.
22. Morais-Cabral J.H., Jackson A.P., Smith C.V., Shikotra N., Maxwell A., Liddington R.C. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 1997, 388:903-906.
23. Oppegaard H., Sørum H. gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida. Antimicrobial Agents and Chemotherapy 1994, 38:2460-2464.
24. Raida M.K., Buchmann K. Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: effects of temperature on protection and gene expression. Vaccine 2008, 26:1050-1062.
25. Rogstad A., Ellingsen O.F., Syvertsen C. Pharmacokinetics and bioavailability of flumequine and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture 1993, 110:207-220.
26. Roozbahani M.R., Bandehpour M., Haghighi-Khiabanian-Asl A., Abdollahi H., Kazemi B. PCR-based detection of Yersinia ruckeri infection in rainbow trout fish. Asian Journal of Animal and Veterinary Advances 2009, 4:258-262.
27. Rucker R. Redmouth disease of rainbow trout (Salmo gairdneri). Bulletin - Office International des Epizooties 1996, 65:825-830.
28. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. Antimicrobial Agents and Chemotherapy 2003, 51:1109-1117.
29. Sallum U.W., Chen T.T. Molecular cloning of cecropin B responsive endonucleases in Yersinia ruckeri. Marine Biotechnology 2011, 13:56-65.
30. Shah S.Q.A., Nilsen H., Bottolfsen K., Colquhoun D.J., Sørum H. DNA gyrase and topoisomerase IV mutations in quinolone resistant Flavobacterium psychrophilum isolated from diseased salmonids in Norway. MDR 2012, 18(2):207-214.
31. Smith P., Douglas I., McMurray J., Carroll C. A rapid method of improving the criteria being used to interpret disc diffusion antimicrobial susceptibility test data for bacteria associated with fish diseases. Aquaculture 2009, 290:172-178.
32. Tobback E.K., Hermans K., Decostere A., Van den Broeck W., Haesebrouck F., Chiers K. Interactions of virulent and avirulent Yersinia ruckeri strains with isolated gill arches and intestinal explants of rainbow trout Oncorhynchus mykiss. Diseases of Aquatic Organisms 2010, 90:175-179.
33. Van Hoek A.H.A.M., Mevius D., Guerra B., Mullany P., Roberts A.P., Aarts H.J.M. Acquired antibiotic resistance genes: an overview. Frontiers in Microbiology 2011, 2:1-27.
34. Wang M., Sahm D.F., Jacoby G., Hooper D. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrobial Agents and Chemotherapy 2004, 48:1295-1299.